507 related articles for article (PubMed ID: 11159735)
1. CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China.
Song N; Tan W; Xing D; Lin D
Carcinogenesis; 2001 Jan; 22(1):11-6. PubMed ID: 11159735
[TBL] [Abstract][Full Text] [Related]
2. CYP1A1 polymorphisms and risk of lung cancer in the ethnic Kashmiri population.
Shaffi SM; Shah MA; Bhat IA; Koul P; Ahmad SN; Siddiqi MA
Asian Pac J Cancer Prev; 2009; 10(4):651-6. PubMed ID: 19827888
[TBL] [Abstract][Full Text] [Related]
3. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Bernges U; Philipp M; Woitowitz HJ
Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
[TBL] [Abstract][Full Text] [Related]
4. Synergistic association of CYP1A1 polymorphisms with increased susceptibility to squamous cell lung cancer in north Indian smokers.
Girdhar Y; Singh N; Behera D; Sharma S
Int J Biol Markers; 2016 Dec; 31(4):e402-e412. PubMed ID: 27396354
[TBL] [Abstract][Full Text] [Related]
5. Risk for K-ras gene mutations in smoking-induced lung cancer is associated with cytochrome P4501A1 and glutathione S-transferase micro1 polymorphisms.
Noda N; Matsuzoe D; Konno T; Kawahara K; Yamashita Y; Shirakusa T
Oncol Rep; 2004 Oct; 12(4):773-9. PubMed ID: 15375499
[TBL] [Abstract][Full Text] [Related]
6. Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types.
Alexandrie AK; Sundberg MI; Seidegård J; Tornling G; Rannug A
Carcinogenesis; 1994 Sep; 15(9):1785-90. PubMed ID: 7923570
[TBL] [Abstract][Full Text] [Related]
7. CYP1A1 gene polymorphisms and smoking status as modifier factors for lung cancer risk.
Hussein AG; Pasha HF; El-Shahat HM; Gad DM; Toam MM
Gene; 2014 May; 541(1):26-30. PubMed ID: 24613751
[TBL] [Abstract][Full Text] [Related]
8. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens.
Le Marchand L; Sivaraman L; Pierce L; Seifried A; Lum A; Wilkens LR; Lau AF
Cancer Res; 1998 Nov; 58(21):4858-63. PubMed ID: 9809991
[TBL] [Abstract][Full Text] [Related]
9. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
10. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study.
Wenzlaff AS; Cote ML; Bock CH; Land SJ; Santer SK; Schwartz DR; Schwartz AG
Carcinogenesis; 2005 Dec; 26(12):2207-12. PubMed ID: 16051642
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population.
Nakachi K; Imai K; Hayashi S; Kawajiri K
Cancer Res; 1993 Jul; 53(13):2994-9. PubMed ID: 8319207
[TBL] [Abstract][Full Text] [Related]
12. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population.
Kihara M; Kihara M; Noda K
Carcinogenesis; 1995 Oct; 16(10):2331-6. PubMed ID: 7586131
[TBL] [Abstract][Full Text] [Related]
13. CYP1A1 Ile462Val polymorphism and the risk of non-small cell lung cancer in a Chinese population.
Lin J; He B; Cao L; Zhang Z; Liu H; Rao J; Liu Y; Shao S; Wang G; Zhang X
Tumori; 2014; 100(5):547-52. PubMed ID: 25343551
[TBL] [Abstract][Full Text] [Related]
14. A case-control study of cytochrome P450 1A1, glutathione S-transferase M1, cigarette smoking and lung cancer susceptibility (Massachusetts, United States).
Garcia-Closas M; Kelsey KT; Wiencke JK; Xu X; Wain JC; Christiani DC
Cancer Causes Control; 1997 Jul; 8(4):544-53. PubMed ID: 9242469
[TBL] [Abstract][Full Text] [Related]
15. Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK.
Wang H; Tan W; Hao B; Miao X; Zhou G; He F; Lin D
Cancer Res; 2003 Nov; 63(22):8057-61. PubMed ID: 14633739
[TBL] [Abstract][Full Text] [Related]
16. Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer.
Shah PP; Singh AP; Singh M; Mathur N; Pant MC; Mishra BN; Parmar D
Mutat Res; 2008 Mar; 639(1-2):1-10. PubMed ID: 18082227
[TBL] [Abstract][Full Text] [Related]
17. A functional polymorphism in the SULT1A1 gene (G638A) is associated with risk of lung cancer in relation to tobacco smoking.
Liang G; Miao X; Zhou Y; Tan W; Lin D
Carcinogenesis; 2004 May; 25(5):773-8. PubMed ID: 14688021
[TBL] [Abstract][Full Text] [Related]
18. Influence of CYP1A1, GSTM1, GSTT1, and NQO1 genotypes and cumulative smoking dose on lung cancer risk in a Swedish population.
Alexandrie AK; Nyberg F; Warholm M; Rannug A
Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):908-14. PubMed ID: 15184245
[TBL] [Abstract][Full Text] [Related]
19. Risk modification by CYP1A1 and GSTM1 polymorphisms in the association of environmental tobacco smoke and lung cancer: a case-control study in Japanese nonsmoking women.
Kiyohara C; Wakai K; Mikami H; Sido K; Ando M; Ohno Y
Int J Cancer; 2003 Oct; 107(1):139-44. PubMed ID: 12925969
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of NAD(P)H quinone oxidoreductase, CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing, China.
Yin L; Pu Y; Liu TY; Tung YH; Chen KW; Lin P
Lung Cancer; 2001; 33(2-3):133-41. PubMed ID: 11551408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]